Loading...
XASX
4DX
Market cap1.56bUSD
Aug 28, Last price  
3.64AUD
Name

4DMedical Ltd

Chart & performance

D1W1MN
XASX:4DX chart
P/E
P/S
372.89
EPS
Div yield, %
Shrs. gr., 5y
-4.10%
Rev. gr., 5y
36.56%
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

4DMedical Limited operates as a medical technology firm with operations spanning both Australia and the United States. A core aspect of its business involves the commercialization of XV Technology, an advanced four-dimensional system for lung imaging. The company's offerings further extend to a software-as-a-service (SaaS) delivery model, alongside its proprietary XV lung ventilation analysis software. Additional products include Permetium, a preclinical imaging system designed to quantify localized changes in pulmonary function, and the AccuVent 200, a ventilator specifically tailored for small animals. Established in 2012, 4DMedical Limited is headquartered in Carlton, Australia.
IPO date
Aug 07, 2020
Employees
131
Domiciled in
AU
Incorporated in
AU

Valuation

No data to show